More information at: Jara et al. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. N Eng J Med 2021; 7 July (DOI: 10.1056/NEJMoa2107715) Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2107715?query=featured_home
Next Thursday, July 1st, to the 14:00 hours will be held the Conference Dr. Osvaldo Cori, with the talk "Study of viruses that infect the nervous system: Applications in neuroscience and gene therapy", in charge of the graduate Esteban Engel, Ph.d., Director of the Viral Neuroengineering Laboratory, Princeton Neuroscience Institute, Princeton University. Link zoom to the talk:...
A comparative study of the effectiveness of 2 vaccines against the COVID-19 variant B.1.617.2, showed that the vaccine “Pfizer- BioNTech BNT162b2 mRNA” is effective in a 88% after two weeks of application of the second dose against variant B.1.617.2 delta and a 93% versus variant B.1.1.7 alpha. The Oxford-Astrazeneca vaccine (ChAdOx1 COVID-19) was less effective..
The University of San Sebastian invites to a series of webinars entitled: Natural bioactive agents and their applications. Webinar 1: Research in bioactive agents and development of phytopharmaceuticals. Thursday, 24 of June of 2021 to the 15:00 -04 Registration at the following link: https://my.demio.com/ref/rwDbIbDUPwiC6Y5M
This course is part of the XVII Latin American Congress of Nutritional Therapy, Clinical Nutrition and Metabolism (from FELANPE), to be realized of the 3 to the 6 July. The link to review the program is: www.felanpe2020.org